← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▲ BUY
10 / 10

Conviction

$ Value

$30.0M

Shares

1,176,470

Price

$26

Filed

Sep 8

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

RA CAPITAL MANAGEMENT, L.P.

Title

CIK

0001346824

Roles

Director

Transaction Details

Transaction Date

2025-09-04

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

5,456,521

Footnotes

Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund"). | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. | Held directly by Nexus Fund III.

Filing Info

Accession No.

0001415889-25-023893

Form Type

4

Issuer CIK

0001933414

RA CAPITAL MANAGEMENT, L.P.'s History

Date Ticker Type Value
2026-04-22 ACRV A $7.0M
2026-04-20 VOR $2.7M
2026-04-17 VOR $7.5M
2026-04-15 VOR $859K
2026-04-14 VOR $2.5M
2026-04-13 VOR $8.6M
2026-04-10 VOR $13K
2026-04-09 VOR $2.2M
2026-04-08 VOR $5.8M
2026-04-08 VOR $2.2M

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31